+

WO1998018951A8 - Systeme de transfert de genes par l'intermediaire de recepteurs pour therapie genique ciblee de tumeurs - Google Patents

Systeme de transfert de genes par l'intermediaire de recepteurs pour therapie genique ciblee de tumeurs

Info

Publication number
WO1998018951A8
WO1998018951A8 PCT/CN1997/000106 CN9700106W WO9818951A8 WO 1998018951 A8 WO1998018951 A8 WO 1998018951A8 CN 9700106 W CN9700106 W CN 9700106W WO 9818951 A8 WO9818951 A8 WO 9818951A8
Authority
WO
WIPO (PCT)
Prior art keywords
transfer system
gene transfer
receptor
gene therapy
oligopeptide
Prior art date
Application number
PCT/CN1997/000106
Other languages
English (en)
French (fr)
Other versions
WO1998018951A1 (fr
Inventor
Jianren Gu
Peikun Tian
Original Assignee
Shanghai Cancer Inst
Jianren Gu
Peikun Tian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Cancer Inst, Jianren Gu, Peikun Tian filed Critical Shanghai Cancer Inst
Priority to US09/092,000 priority Critical patent/US6339139B1/en
Priority to JP51985998A priority patent/JP2001503617A/ja
Priority to EP97910196A priority patent/EP0900849A4/en
Priority to AU47702/97A priority patent/AU4770297A/en
Priority to CA002241923A priority patent/CA2241923C/en
Publication of WO1998018951A1 publication Critical patent/WO1998018951A1/zh
Publication of WO1998018951A8 publication Critical patent/WO1998018951A8/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PCT/CN1997/000106 1996-10-31 1997-10-27 Systeme de transfert de genes par l'intermediaire de recepteurs pour therapie genique ciblee de tumeurs WO1998018951A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/092,000 US6339139B1 (en) 1996-10-31 1997-10-27 Receptor-mediated gene transfer system for targeting tumor gene therapy
JP51985998A JP2001503617A (ja) 1996-10-31 1997-10-27 標的化腫瘍遺伝子治療のためのレセプターを介した遺伝子移送系
EP97910196A EP0900849A4 (en) 1996-10-31 1997-10-27 RECEPTOR-MEDIATED GENE TRANSFER SYSTEM FOR TARGET-SPECIFIC GENE THERAPY
AU47702/97A AU4770297A (en) 1996-10-31 1997-10-27 Receptor-mediated gene transfer system for targeting tumor gene therapy
CA002241923A CA2241923C (en) 1996-10-31 1997-10-27 Receptor-mediated gene transfer system for targeting tumor gene therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN96116557A CN1181422A (zh) 1996-10-31 1996-10-31 与生长因子受体结合的多肽所构建的基因转移载体
CN96116557.X 1996-10-31

Publications (2)

Publication Number Publication Date
WO1998018951A1 WO1998018951A1 (fr) 1998-05-07
WO1998018951A8 true WO1998018951A8 (fr) 1999-06-24

Family

ID=5123655

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN1997/000106 WO1998018951A1 (fr) 1996-10-31 1997-10-27 Systeme de transfert de genes par l'intermediaire de recepteurs pour therapie genique ciblee de tumeurs

Country Status (7)

Country Link
US (1) US6339139B1 (zh)
EP (1) EP0900849A4 (zh)
JP (1) JP2001503617A (zh)
CN (1) CN1181422A (zh)
AU (1) AU4770297A (zh)
CA (1) CA2241923C (zh)
WO (1) WO1998018951A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930533D0 (en) * 1999-12-23 2000-02-16 Mitsubishi Tokyo Pharm Inc Nucleic acid delivery
US6897067B2 (en) 2000-11-03 2005-05-24 Regents Of The University Of Michigan Surface transfection and expression procedure
WO2002042447A2 (en) * 2000-11-03 2002-05-30 Regents Of The University Of Michigan Surface transfection and expression procedure
US6902933B2 (en) 2000-11-03 2005-06-07 Regents Of The University Of Michigan Surface transfection and expression procedure
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
EP1496979A4 (en) * 2002-03-22 2007-10-31 Univ Texas PROTAMINE-ADENOVIRAL VECTOR COMPLEXES AND APPLICATION METHODS
US6835810B2 (en) * 2002-05-13 2004-12-28 Geneshuttle Biopharma, Inc. Fusion protein for use as vector
NZ538284A (en) * 2002-07-18 2008-04-30 Helix Biopharma Corp Use of urease and targeting molecule for inhibiting cancer cell growth
CN1470531A (zh) * 2002-07-24 2004-01-28 上海新世界基因技术开发有限公司 以组蛋白为核心序列的靶向性基因导入系统
CN100553682C (zh) * 2003-06-11 2009-10-28 中国医学科学院基础医学研究所 G型非病毒载体以及包含其的药物组合物
CN100522250C (zh) * 2003-06-11 2009-08-05 中国医学科学院基础医学研究所 N型非病毒载体以及包含其的药物组合物
EP1646684A4 (en) * 2003-06-30 2010-09-29 Canji Inc POLYMER ENCAPSULATION OF ADENOVIRUS
CN101104856B (zh) * 2003-11-18 2010-11-10 中国医学科学院基础医学研究所 一个系列的非病毒载体及包含其的药物组合物
CN100493618C (zh) * 2003-11-18 2009-06-03 中国医学科学院基础医学研究所 一个系列的非病毒载体及包含其的药物组合物
CA2555274A1 (en) 2004-02-05 2005-08-25 The Ohio State University Research Foundation Chimeric vegf peptides
CN100356981C (zh) * 2004-03-31 2007-12-26 上海新世界基因技术开发有限公司 与人表皮生长因子受体egfr特异性结合的配体寡肽
ES2531483T3 (es) * 2005-06-15 2015-03-16 The Ohio State University Research Foundation Péptidos HER-2
EP2334693A4 (en) * 2008-07-18 2011-09-21 Chee Keong Choo METHODS OF LONG-TERM CULTURE OF EUKARYOTIC CELLS AND USES THEREOF
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
RU2529034C2 (ru) * 2012-12-28 2014-09-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) Модульный молекулярный конъюгат для направленной доставки генетических конструкций и способ его получения

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
DK0532525T3 (da) * 1990-05-18 1995-12-04 Genentech Inc Nye protein-polykationkonjugater
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
JPH08510391A (ja) * 1994-03-18 1996-11-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション Ｍｔｓ遺伝子における生殖系統の変異およびｍｔｓ遺伝子における癌の素因の検出方法
WO1996006641A1 (en) * 1994-08-29 1996-03-07 Prizm Pharmaceuticals, Inc. Conjugates of vascular endothelial growth factor with targeted agents
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US5843659A (en) * 1996-03-21 1998-12-01 Apoptosis Technology, Inc. Apoptosis gene EI24, compositions, and methods of use

Also Published As

Publication number Publication date
JP2001503617A (ja) 2001-03-21
EP0900849A4 (en) 2000-11-02
CA2241923A1 (en) 1998-05-07
WO1998018951A1 (fr) 1998-05-07
AU4770297A (en) 1998-05-22
CA2241923C (en) 2003-12-30
US6339139B1 (en) 2002-01-15
EP0900849A1 (en) 1999-03-10
CN1181422A (zh) 1998-05-13

Similar Documents

Publication Publication Date Title
WO1998018951A8 (fr) Systeme de transfert de genes par l'intermediaire de recepteurs pour therapie genique ciblee de tumeurs
Zimmer et al. Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material
EP1953229A3 (en) Metastatic breast and colon cancer regulated genes
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
WO1999035170A8 (en) Compositions and methods for the treatment of tumor
EP1038967A3 (en) Virus with modified binding moiety specific for the target cells
EP1396548A3 (en) Nucleic acid mutation detection in histologic tissue
GB9623051D0 (en) Delivery of DNA to target cells in biological systems
EP2028270A3 (en) Modified recombinant vaccinia viruses and other microorganisms, uses thereof
WO1997026910A3 (de) Tumorimpfstoff für die immuntherapie von malignen tumoren
WO2002010382A3 (en) Trp8, trp9 and trp10, markers for cancer
EP1683811A3 (en) Compositions and methods for the treatment of tumors
EP1734134A3 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
HK1045641A1 (en) Targeted liposome gene delivery
WO2001004334A3 (en) Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car)
WO2002010368A1 (fr) Promoteurs specifiques de tumeur
EP1642906A3 (en) Composition and methods for the diagnosis of tumours
WO2000029551A3 (en) Cells, culture methods, and their use in autologous transplantation therapy
WO2000015666A3 (en) Compositions and methods for the treatment of tumors
CA2283536A1 (en) Compositions and methods for elimination of unwanted cells
WO2000055193A3 (en) Human dan/cerberus related protein 6 (dcr6)
CA2315239A1 (en) Nucleotide and protein sequence of mammastatin and methods of use
WO2000071711A3 (en) Differentially expressed genes in prostate cancer
WO2001009173A3 (fr) Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose
EP1214942A3 (de) Verwendung von mit Bacteriophagen, die ein tumorspezifisches und/oder tumorassoziliertes Antigen auf ihrer Oberfläche tragen, beladenen dendritischen Zellen zur Behandlung von Tumoren

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

ENP Entry into the national phase

Ref document number: 2241923

Country of ref document: CA

Ref document number: 2241923

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997910196

Country of ref document: EP

Ref document number: 97191515.6

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 1998 519859

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09092000

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997910196

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (81) ADD "AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN"

WWW Wipo information: withdrawn in national office

Ref document number: 1997910196

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载